FDA Allows IND for DiscGenics’ Clinical Study
FDA accepted DiscGenics’ Investigational New Drug Application for a clinical study of its cell therapy product candidate to treat degenerative disc disease. Oct 03, 2017
Spineology Fully Launches Elite Expandable Interbody Fusion System
Spineology commenced full market release of the Elite™ Expandable Interbody Fusion system. More than 300 cases have been completed since limited launch in 2Q16. Oct 03, 2017
Zimmer Biomet Launches Avenue T TLIF Cage with VerteBRIDGE Plating
Zimmer Biomet commenced U.S. launch of the Avenue® T TLIF Cage, featuring self-guided, curved VerteBRIDGE® plating. Oct 03, 2017
Musculoskeletal Transplant Foundation Rebrands as MTF Biologics
Musculoskeletal Transplant Foundation changed its name to MTF Biologics. Oct 03, 2017
OrthAlign Gains CE Mark Approval for DAA HipAlign and UniAlign
OrthAlign received CE Mark Approval to market the DAA HipAlign® Direct Anterior Approach Total Hip system and UniAlign® Unicompartmental Knee Arthroplasty. Oct 03, 2017
Vivorte Launches New Bone Graft Products
Vivorté launched FORTERA™ and REGENTO™ bone graft products for orthopaedic surgery. Oct 03, 2017
CartiHeal Initiates Agili-C Implant IDE Multinational Pivotal Study
CartiHeal enrolled and treated 16 patients in its IDE study of Agili-C™ implants in the treatment of joint surface lesions. Oct 02, 2017
OrthoPediatrics Launches IPO
OrthoPediatrics launched its initial public offering of 4MM shares of common stock, with a proposed offering price of $12-$14/share. Oct 02, 2017
NN, Inc. Acquires DRT Medical
NN, Inc. acquired DRT Medical, supplier of precision manufactured orthopaedic implants and instruments. Financial terms were not disclosed. Oct 02, 2017
K2M Receives FDA Clearance for YUKON OCT System
K2M received FDA 510(k) clearance to market the YUKON™ OCT system to support fusion with posterior fixation in the occipito-cervico-thoracic spine. Sep 29, 2017
